Multicenter study assessing the ability of clinical and molecular panel as predictive determinant of efficacy of regorafenib in metastatic colorectal cancer patients.
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2016
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms REINVENT
- 07 Dec 2016 New trial record
- 11 Oct 2016 Trial design presented at 41st European Society for Medical Oncology Congress.